| Stable plinabulin formulations and methods of their preparation and use |
2023-2-08 |
2023-8-17 |
|
| Tubulin binding compounds and therapeutic use thereof |
2022-12-23 |
2023-3-01 |
|
| Triple combination therapy for enhancing cancer cell killing in cancers with … |
2022-11-02 |
2023-1-01 |
|
| Use of plinabulin in combination with immune checkpoint inhibitors |
2022-11-01 |
2022-12-22 |
|
| Method of reducing neutropenia |
2022-10-25 |
2022-12-27 |
|
| Methods for treating cancers and tumors |
2022-10-06 |
2023-4-13 |
|
| Therapeutic compositions and methods for treating tumors |
2022-4-07 |
2022-10-13 |
|
| Compositions containing tucaresol or its analogs |
2022-4-07 |
2022-6-14 |
|
| Plinabulin compositions |
2022-2-18 |
2022-6-02 |
|
| Composition and method for reducing neutropenia |
2022-2-10 |
2022-4-12 |
|
| Method of treating cancer associated with a RAS mutation |
2021-12-21 |
2022-1-27 |
|
| Compositions and methods for generating anti-tumor immune response |
2021-12-17 |
2022-6-23 |
|
| Method of treating a brain tumor |
2021-10-19 |
2021-11-18 |
|
| Impurities in plinabulin or preparations thereof and uses thereof |
2021-8-13 |
2023-2-17 |
|
| Tucaresol derivatives and uses thereof |
2020-11-09 |
2021-5-20 |
|
| Methods and compositions for treating iron disorders |
2020-10-13 |
2022-8-24 |
|
| Composition and method for reducing chemotherapy-induced neutropenia via the … |
2020-7-21 |
2020-9-30 |
|
| Composition and method for reducing thrombocytopenia via the administration of … |
2020-7-19 |
2020-9-30 |
|
| Cancer treatment with combination of plinabulin and taxane |
2020-3-17 |
2020-9-10 |
|
| How to use a tubulin binding agent to treat cancer |
2019-11-12 |
2021-7-22 |
|
| Method and composition for stimulating immune response |
2019-8-16 |
2022-5-11 |
|
| Composition and method of treating cancer associated with EGFR mutation |
2019-5-30 |
2020-12-24 |
|
| Cancer treatment with combination of plinabulin and taxane |
2018-9-26 |
2018-12-20 |
|
| Compositions of plinabulin and use thereof |
2018-3-12 |
2018-9-20 |
|
| Method of reducing neutropenia |
2018-2-01 |
2022-3-01 |
|
| COMPOSITION AND METHOD TO REDUCE NEOTROPENIA |
2017-6-06 |
2018-9-26 |
|
| Composition and method for reducing neutropenia |
2017-6-05 |
2021-3-02 |
|
| Cancer treatment with a combination of plinabulin and taxane |
2016-4-08 |
2016-12-02 |
|
| Method of treating a brain tumor |
2016-3-02 |
2020-11-27 |
|
| Method of treating a brain tumor |
2016-3-02 |
2021-3-02 |
|
| Use of plinabulin in combination with immune checkpoint inhibitors |
2016-2-11 |
2021-6-29 |
|
| Cancer treatment with combination of plinabulin and taxane |
2013-10-11 |
2018-5-30 |
|
| Analogs of dehydrophenylahistins and their therapeutic use |
2012-7-12 |
2012-11-01 |
|
| Interleukin-1 and tumor necrosis factor-alpha modulators; syntheses of such … |
2011-1-14 |
2011-6-30 |
|
| Analogs of dehydrophenylahistins and their theapeutic use |
2007-11-02 |
2008-9-11 |
|
| Dehydrophenylahistins and analogs thereof and the synthesis of … |
2006-6-07 |
2006-10-05 |
|
| Synthesis of diketopiperazines |
2006-3-27 |
2006-10-19 |
|
| Cell division inhibitors and process for producing the same |
2005-12-07 |
2009-9-03 |
2009-9-03 |
| Dehydrophenylahistins and analogs thereof and the synthesis of … |
2005-2-04 |
2011-5-03 |
2011-5-03 |
| Dehydrophenylahistins and analogs thereof and the synthesis of … |
2003-8-01 |
2014-4-30 |
2014-4-30 |